Latest in Ozempic parent’s stock having worst day since the 1980s as new weight loss drug disappoints
Sort by
2,786 items
-
In shift, RFK Jr. now says weight-loss drugs 'have a place'
His remarks come days before he holds confirmation meetings with GOP senators.ABC News - Dec. 12 -
Millions mark Mexico's Virgin of Guadalupe Day but calls for a truce in drug violence go unheeded
Millions of faithful have gathered to mark Mexico’s Virgin of Guadalupe Day, honoring the country's patronessABC News - Dec. 12 -
Elon Musk contradicts RFK Jr.'s sentiments on weight loss drugs
Elon Musk validated the use of GLP-1 drugs in a post on X on Wednesday. But Robert F. Kennedy Jr. has said he's opposed to Americans using them to fight obesity.ABC News - Dec. 12 -
-
On Ozempic? Big Food Makers Have a New Label for You
Conagra Brands is adding “GLP-1 friendly” to packaging on Healthy Choice frozen meals to woo users of weight-loss drugs.The Wall Street Journal - Dec. 12 -
Cigna’s stock leads selloff among drug middlemen on breakup fears — but this analyst says it’s not a real risk
One influential healthcare analyst says the chances of such a bill passing are less than 5%.MarketWatch - Dec. 12 -
What other conditions could weight-loss drugs treat?
Initial research has focused on obesity, but Ozempic, Wegovy and Mounjaro may potentially be used for addiction, heart disease and Alzheimer’sFinancial Times - Dec. 12 -
Lawmakers Push Bill to Break Up Drug Middlemen, Affecting Stocks
A small number of groups control the majority of pharmacy benefit managers in the U.S.Inc. - Dec. 11 -
Alphabet’s stock having best 2-day run in a decade as the good news keeps coming
Google parent Alphabet’s stock is having its best two-day run in nine years amid good news on the quantum-computing and Waymo fronts.MarketWatch - Dec. 11 -
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
It is made possible through a first-of-a-kind integration with Eli Lilly's direct-to-consumer website, and aims to streamline access to the popular treatment.CNBC - Dec. 11 -
New guidance on 'parental alienation' in family court battles
Family Courts should give more weight to allegations of domestic abuse than to claims of so called "parental alienation", it saysBBC News - Dec. 11 -
Insurance stocks have fallen since UnitedHealthcare CEO killing
Major insurance stocks have fallen since their closing prices last Tuesday, the day before the deadly shooting of UnitedHealthcare CEO Brian Thompson.CNBC - Dec. 10 -
Walgreens’ stock on pace for its best day ever on report of talks of sale to private equity — but still on pace for its worst year
Shares of Walgreens Boots Alliance Inc. launched higher on Tuesday after the Wall Street Journal reported that the drugstore chain was in discussions to sell itself to private-equity firm Sycamore ...MarketWatch - Dec. 10 -
The London Stock Exchange suffers another loss to the U.S.
The FTSE 100 equipment rental company said moving its primary listing to the U.S. increase it exposure to investors and allow for its inclusion in “premier U.S. equity indices.”MarketWatch - Dec. 10 -
Beneath the hood, stocks just suffered their worst day of the year. Some are worried.
Momentum stocks quietly just had their worst day of the year. History points to a mixed experience when that happens.MarketWatch - Dec. 10 -
‘I’m at a loss’: My boyfriend of nearly 10 years is naming his elderly parents as beneficiaries and giving them power of attorney. Am I right to be upset?
“I own the house we live in and he pays me a small amount of rent every month to help cover my mortgage and utilities.”MarketWatch - Dec. 10 -
Some health experts warn against microdosing weight loss drugs
The demand for weight loss drugs, like Ozempic and Wegovy, has skyrocketed in the past few years despite the high cost and unpleasant side effects for some people. The New York Times reports some ...CBS News - Dec. 9 -
Mondelez is reportedly exploring a Hershey acquisition. Drugs like Ozempic could justify a deal.
Shares of Hershey Co. booked a double-digit percentage gain on Monday after Bloomberg reported that Oreo maker Mondelez International Inc. was exploring a possible acquisition of the iconic ...MarketWatch - Dec. 10 -
AppLovin’s S&P 500 snub makes for the stock’s worst day in 2 years
AppLovin’s $135 billion market cap and 900% year-to-date surge through Friday’s close weren’t enough to earn it entry into the benchmark large-cap index.MarketWatch - Dec. 9 -
South Carolina reasserting dominance since UCLA loss: Chloe Kitts' emergence lifting refocused Gamecocks
Dawn Staley's team has reeled off back-to-back wins over top-10 opponents since its loss to UCLACBS Sports - Dec. 9 -
Giants' latest 'disappointing' loss keeps hope of landing No. 1 pick alive
Graham Gano’s miss sealed the Giants’ 14-11 loss to the lowly Saints. More importantly: It kept the possibility of the No. 1 pick in the NFL Draft alive.Yahoo Sports - Dec. 9 -
Durbin on Hunter Biden pardon: 'If I have to have a bias in this area, it's a loving parent who wants to protect his child'
Sen. Dick Durbin (D-Ill.) on Sunday noted the past trauma in President Biden’s family when talking about his recent pardon of his son Hunter Biden. “This is a man who loves his children and has ...The Hill - Dec. 8 -
The weight-loss drug boom has become one of the internet's biggest scams
As demand for obesity drugs like Wegovy, Zepbound, Mounjaro and Ozempic, outpaces supply, online scams are rising, according to cybersecurity experts.CNBC - Dec. 8 -
The Spectrum review – a tactile trip to the 1980s
This latest piece of modern vintage hardware from Retro Games Ltd makes for an astonishingly nostalgic experience. The first time I played on a ZX Spectrum was at the Stockport branch of Debenhams, ...The Guardian - Dec. 6 -
Intel adds some much-needed help to its board, with stock on track for its worst year ever
Intel Corp.’s much-needed addition of two executives with semiconductor expertise to its board comes as the chip maker’s stock is on track for its worst year ever, after the ouster earlier this ...MarketWatch - Dec. 6 -
Weight-loss drug Mounjaro 'changed my life,' says mother-of-two
People struggling with their weight welcome the NHS rollout of Mounjaro but worry about delays.BBC News - Dec. 5 -
The Allure of ‘Microdosing’ Ozempic
Some people are taking tiny amounts of weight loss medications, hoping to drop pounds while avoiding side effects. Does it work?The New York Times - Dec. 5 -
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
The jump in prescription fills comes despite limited insurance coverage and high out-of-pocket costs for Novo Nordisk's Wegovy and Eli Lilly's Zepbound.CNBC - Dec. 5 -
Millions will have to wait up to 12 years for NHS weight-loss drug
Fears that giving 3.4 million people immediate access to new weight-loss drug could overwhelm NHS.BBC News - Dec. 5 -
Tech stocks hit first all-time high since July
Technology stocks powered to new highs on Wednesday as the tech-heavy Nasdaq Composite rallied 1% and investors poured into key software and megacap players.CNBC - Dec. 4 -
Oklahoma State fires offensive, defensive coordinators after posting worst winning percentage since 1991
The Cowboys are making major staff changes after stumbling to an 0-9 record in conference playCBS Sports - Dec. 4 -
Will Trump nix Biden’s coverage plan for weight-loss drugs? It’ll be a close call.
While President-elect Donald Trump looks poised to scrap many policies of the Biden administration, one veteran analyst says it’s possible he could end up supporting the Democratic incumbent’s ...MarketWatch - Dec. 4 -
Zepbound brings more weight loss than Wegovy: Drugmaker
Adults who take Zepbound lose more weight than those who take competitor weight loss drug Wegovy, according to new clinical trial results. Zepound manufacturer Eli Lilly released results from their ...The Hill - Dec. 4 -
Eli Lilly says Zepbound’s weight-loss results beat those of rival Wegovy
Zepbound helped patients lose more weight than a major rival in a head-to-head trial.MarketWatch - Dec. 4 -
A rival weight loss drug to Wegovy helped people shed more pounds, study shows
People who took Zepbound, Eli Lilly’s weight loss drug, shed more pounds than those on Novo Nordisk’s Wegovy in a clinical trial, Lilly said in a release Wednesday.NBC News - Dec. 4 -
Share with parents or rent forever: ‘I have put life on hold while trying to buy a house’
Thanks to the housing crisis, Australians are learning to live together in ways previously associated with students and twentysomethings. Can we accept it as the new norm?. Read other stories in ...The Guardian - Dec. 4 -
Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial
Zepbound's greater weight loss is a huge advantage for Eli Lilly, which is competing with Novo Nordisk for a larger share of the weight loss drug market.CNBC - Dec. 4 -
The teams that have impressed (TCU!) and disappointed (USC) one month into the season
From JuJu Watkins and USC to Paige Bueckers and UConn, we break down what's happened so far.ESPN - Dec. 4 -
DNC chair minimizes November losses, argues Democrats have ‘robust’ foundation
Democratic National Committee (DNC) Chair Jaime Harrison minimized his party’s losses up and down the ballot in November and argued Democrats have a “robust” foundation to build on, going into ...The Hill - Dec. 3 -
Experts create controllable gastric balloon to aid weight loss
Device inflates before eating and contracts afterwards, simulating the effects of having a meal, say scientists. From weight loss jabs to vibrating pills , the obesity crisis has spawned myriad ...The Guardian - Dec. 3
